North East and North Cumbria
ICS Formulary
 
back
6 Endocrine system
06-06-02 Bisphosphonates and other drugs affecting bone metabolism

Burosumab  Crysvita®
Formulary
  • 10mg, 20mg & 30mg solution for injection
  • Approved for treating X-linked hypophosphataemia in children and young people in accordance with NICE
  • Approved for treating X‑linked hypophosphataemia (XLH) in adults - Please note that only the following provider is commissioned to provide this service within the North East & Cumbria Hub: The Newcastle upon Tyne Hospitals NHS Foundation Trust
Link  NICE HST 8: Burosumab for treating X-linked hypophosphataemia in children and young people
Link  NICE TA993 : Burosumab for treating X-linked hypophosphataemia in adults

Red View adult BNF  View SPC online  View childrens BNF